摘要
目的：评价降钙素原（PCT）对急性心肌梗塞患者预后的价值。方法：分别测定50例健康者和急性心肌梗塞（AMI）患者血清中PCT含量。结果：急性心肌梗塞患者血清中PCT含量较正常组明显升高（P＜0.01），早期AMI患者中，PCT阳性率要高于CK-MB和cTNI。结论：在急性心肌梗塞患者血清中，PCT含量显著增高是预后不良的一个预测因子。
Objective：Evaluation of procalcitonin （PCT） in predicting the prognosis of patients with acute myocardial infarction value .Methods：50 healthy persons and 50 patients with AMl were prospectively studied,Serum concentrations of PCT were respectivelvely measured.Results： The serum concentrations of PCT were higher in patients with AMI than those in normal group（P〈0.01）.In early AMI patients, the positive rate of PCT was higher than that of CK-MB and cTNI.Conclusions：In the serum of patients with AMI,incerased PCT is a predictor of worse porguosis.
出处
《医学检验与临床》
2014年第5期12-13,共2页
Medical Laboratory Science and Clinics
关键词
降钙素原
急性心肌梗塞
Procalcitonin
Acute myocardial infarction
